Silo Pharma Stock Target Price
SILO Stock | USD 1.84 0.05 2.65% |
Silo Pharma fundamentals help investors to digest information that contributes to Silo Pharma's financial success or failures. It also enables traders to predict the movement of Silo OTC Stock. The fundamental analysis module provides a way to measure Silo Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Silo Pharma otc stock.
Silo |
Silo Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Silo Pharma's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Silo Pharma could also be used in its relative valuation, which is a method of valuing Silo Pharma by comparing valuation metrics of similar companies.Silo Pharma is currently under evaluation in target price category among related companies.
Silo Fundamentals
Return On Equity | -0.44 | ||||
Return On Asset | -0.25 | ||||
Operating Margin | (53.47) % | ||||
Current Valuation | (2.06 M) | ||||
Shares Outstanding | 2.84 M | ||||
Shares Owned By Insiders | 6.34 % | ||||
Shares Owned By Institutions | 5.60 % | ||||
Number Of Shares Shorted | 61.39 K | ||||
Price To Earning | 118.39 X | ||||
Price To Book | 0.93 X | ||||
Price To Sales | 77.69 X | ||||
Revenue | 72.1 K | ||||
Gross Profit | 66.26 K | ||||
EBITDA | (3.86 M) | ||||
Net Income | (3.63 M) | ||||
Cash And Equivalents | 8.85 M | ||||
Cash Per Share | 4.45 X | ||||
Current Ratio | 33.28 X | ||||
Book Value Per Share | 2.12 X | ||||
Cash Flow From Operations | (3.22 M) | ||||
Short Ratio | 0.46 X | ||||
Earnings Per Share | (1.18) X | ||||
Target Price | 10.0 | ||||
Beta | 1.35 | ||||
Market Capitalization | 5.6 M | ||||
Total Asset | 7.75 M | ||||
Retained Earnings | (10.87 M) | ||||
Working Capital | 6.91 M | ||||
Net Asset | 7.75 M |
About Silo Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Silo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Silo Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Silo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Silo Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Silo Pharma's short interest history, or implied volatility extrapolated from Silo Pharma options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silo Pharma. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Silo OTC Stock analysis
When running Silo Pharma's price analysis, check to measure Silo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silo Pharma is operating at the current time. Most of Silo Pharma's value examination focuses on studying past and present price action to predict the probability of Silo Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silo Pharma's price. Additionally, you may evaluate how the addition of Silo Pharma to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |